Immoderata Tech #12
Welcome to the latest edition of Immoderata Tech.
For the investors in our audience, we have a few great deals in the pipeline that we will be offering to syndicate members. If you are potentially interested in investing, feel free to join us and gain access to excellent deal flow.
Let’s dive in.
FinTech
A breakdown of the ruling on Ripple's status as a financial security and the potential implications for the crypto industry and the SEC's jurisdiction over it… more here.
Truist joins IBM’s quantum accelerator program, as the bank bets that quantum computing will transform banking… more here.
Big Data and AI
Meta has a new image generator that it claims is best-in-class, try it for yourself… more here.
AI-generated content is starting to pollute the internet… more here.
It is not enough to have a good mind; the main thing is to use it well.
Rene Descartes
Climate
Efforts to standardize carbon credit redemption are moving forward as VCMI releases its rulebook on the credible use of credits… more here.
Climate funding is down 40% YoY, as macro weighs on investors’ willingness to deploy capital… more here.
Digital Health
Researchers have developed a machine learning model capable of predicting surgery patients at risk of post-operation complications… more here.
Bayer launches precision health division to ramp up its development of consumer-facing digital health products… more here.
Give me a lever long enough and a fulcrum on which to place it, and I shall move the world.
Archimedes
Cloud
Cloud service providers edge towards competing on price in the competition for generative AI business… more here.
VMware is collaborating with other industry players to accelerate the adoption of confidential computing… more here.
Ecosystem
Startups are beginning to explore sales (or bankruptcy) as funding runs dry… more here.
A warning on taking lessons from the success of others before understanding what actually happened… more here.
I don't have any magical ability. I look at a problem, play with it, work out a strategy.
Terence Tao
Until next time,
Eric
P.S. - Feel free to email us or text with questions, comments, or feedback. We love hearing from you!
This newsletter does not constitute an offering or form part of any offering or any solicitation of any offer to subscribe to or purchase any investment by Immoderata, LLC, nor shall it or the fact of its distribution form the basis of, or be relied upon in connection with any contract therefore. Any such offer will be made only by means of definitive investment offering documents. The information included in this newsletter is subject to change without notice to any recipient.